Assessment of therapeutic response of plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 6, 1999, Pages 968-972

  Osorio, Lyda Elena ^a   Giraldo, Luis Ernesto ^a   Grajales, Luis Fernando ^a   Arriaga, Ana Luisa ^b   Andrade, Ana Lucia S S ^c   Ruebush II, Trenton K ^d   Barat, Lawrence M ^d  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b Depto Administrativo Salud Choco   (Colombia)

^c PAN AMERICAN HEALTH ORGANIZATION   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLOMBIA; DRUG EFFICACY; FEMALE; HUMAN; INFANT; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0033388509     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.968     Document Type: Article

References (23)

1. Moore DV, Lanier SE, 1961. Observations on two Plasmodium infections with an abnormal response to chloroquine. Am J Trop Med Hyg 10: 5-9.
2. Comer RD, Young MD, Porter JA, Gauld JR, Merritt W, 1968. Chloroquine resistance in Plasmodium falciparum malaria on the Pacific coast of Colombia. Am J Trop Med Hyg 17: 795-799.
3. Espinal CA, Cortes GT, Guerra P, Arias AR, 1985. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 34: 675-680.
4. Botero D, Restrepo M, Montoya A, 1985. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compare with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria. Bull World Health Organ 63: 731-737.
5. Barat LM, Himonga B, Nkunika S, Ettling M, Ruebush TK, Kapelwa W, Bloland PB, 1998. A systematic approach to the development of a rational malaria treatment policy in Zambia. Trop Med Int Health 3: 535-542.
6. World Health Organization, Division of Control of Tropical Diseases, 1996. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Geneva: World Health Organization, WHO/MAL/96.1077.
7. World Health Organization, 1990. Practical chemotherapy of malaria. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 805.
8. Churchill FC, 1989. Field-adapted assays for chloroquine and its metabolites in urine and blood. Parasitol Today 5: 116, 121-126.
9. Mount DL, Green MD, Zucker JR, Were JBO, Todd GD, 1996. Field detection of sulfonamides in urine: the development of a new and sensitive test. Am J Trop Med Hyg 55: 250-253.
10. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Working Group. World Health Organ Tech Rep Ser 529: 30.
11. Organización Panamericana de la Salud, 1998. Evaluación de la eficacia terapéutica de los medicamentos para el tratamiento del paludismo por Plasmodium falciparum sin complicaciones en las américas. OPS/HCP/HCT/113/98.
12. Fleiss J, 1981. Statistical Methods for Rates and Proportions. New York: John Wiley and Sons, 217-219.
13. Soto J, Martinez R, Fonschiffrey G, Dember J, 1995. Efficacy of Fansidar for acute uncomplicated malaria due to Plasmodium falciparum in Colombia. Trans R Soc Trop Med Hyg 89: 306.
14. World Health Organization, 1994. Antimalarial Drug Policies: Data Requirements, Treatment of Uncomplicated Malaria and Management of Malaria in Pregnancy. Geneva: World Health Organization, WHO/MAL/94.1070.
15. Bloland PB, Kazembe PN, Oloo AJ, Himonga B, Barat LM, Ruebush TK, 1998. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop Med Int Health 3: 543-552.
16. Shapira A, Beales PF, Halloran ME, 1993. Malaria: living with drug resistance. Parasitol Today 9: 168-174.
17. Peters W, 1998. Drug resistance in malaria parasites of animals and man. Adv Parasitol 41: 1-62.
18. Aramburu J, Ramal C, Witzig R, 1999. Malaria re-emergence in the Peruvian Amazon region. Emerg Infect Dis 5: 209-215.
19. Barat LM, Bloland PB, 1997. Drug resistance among malaria and other parasites. Infect Dis Clin North Am 11: 969-987.
20. Rallón NI, Osorio LE, Giraldo LE, 1999. Lack of correlation between the Asn-108 mutation in the dihydrofolate reductase gene and in vivo resistance to sulfadoxine/pyrimethamine in Plasmodium falciparum. Am J Trop Med Hyg 61: 245-248.
21. Wernsdorfer WH, 1994. Epidemiology of drug resistance in malaria. Acta Trop 56: 143-156.
22. Baird K, 1998. Age-dependent characteristics of protection vs. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 92: 367-390.
23. White N, 1992. Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol 34: 1-10.